Autonomic Dysfunction clinical trials

Explore recruiting autonomic dysfunction clinical trials.

Recruiting autonomic dysfunction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Autonomic Dysfunction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-341 in Subjects With Multiple System Atrophy

Denmark, Italy, Portugal, Spain, Germany, France +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized adaptive assessment of post COVID syndrome treatments (RAPID) Reducing Inflammatory Activity in Patients with post COVID Syndrome (REVIVE)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo in mild cognitive impairment associated with Parkinson's disease.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Autonomic Dysfunction trials by city

Autonomic Dysfunction in Toronto Autonomic Dysfunction in Vancouver Autonomic Dysfunction in Montreal Autonomic Dysfunction in Calgary Autonomic Dysfunction in Edmonton Autonomic Dysfunction in Ottawa Autonomic Dysfunction in Winnipeg Autonomic Dysfunction in Quebec City Autonomic Dysfunction in Hamilton Autonomic Dysfunction in Kitchener Autonomic Dysfunction in London Autonomic Dysfunction in Halifax Autonomic Dysfunction in New York Autonomic Dysfunction in Los Angeles Autonomic Dysfunction in Chicago Autonomic Dysfunction in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease